p53 Gene Alterations in Prostate Cancer After Radiation Failure and Their Association with Clinical Outcome: A Molecular and Immunohistochemical Analysis
- 31 December 1999
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 195 (3) , 129-135
- https://doi.org/10.1016/s0344-0338(99)80024-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Predictors For Maximal Outcome in Patients Undergoing Salvage Surgery For Radio-Recurrent Prostate CancerUrology, 1998
- p53 Status and Prognosis of Locally Advanced Prostatic Adenocarcinoma: a Study Based on RTOG 8610JNCI Journal of the National Cancer Institute, 1997
- Tumor suppressor gene P53 mutations in human prostate cancerThe Prostate, 1995
- Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damageBioEssays, 1995
- p53 in Prostate Cancer: Frequent Expressed Transition MutationsJNCI Journal of the National Cancer Institute, 1994
- p53 In tumour pathology: Can we trust immunohistochemistry?—revisited!The Journal of Pathology, 1994
- Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Frequency of residual neoplasm in the prostate following three‐dimensional conformal radiotherapyThe Prostate, 1993
- Biopsy after External Beam Radiation Therapy for Adenocarcinoma of the Prostate: Correlation with Original Histological Grade and Current Prostate Specific Antigen LevelsJournal of Urology, 1991
- Codon 72 polymorphism of the TP53 geneNucleic Acids Research, 1990